FDA NDC Directory · JSON-LD · Markdown

Teriflunomide

NDC 69339-169 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerNatco Pharma USA LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA209555
Dosage form / routeTABLET · ORAL
Active ingredientsTERIFLUNOMIDE (7 mg/1)
Marketing started20230617
Package count3

External sources

Source: openFDA. Public-domain (CC0).